Tag: markers

Quick Search


Hormone-Refractory Prostate Cancer: A Continuum of Diseases and Options

Tue 1 Nov 2005

By Oliver Sartor, M.D., Chief, Hematology-Oncology Section; Director, Stanley S. Scott Cancer Center, LSU Medical Center, New Orleans Edited from PCRI Insights November, 2005 vol. 8 no.4 Introduction It is possible that hormones can sometimes cure, but unfortunately, that seems to be true only in a minority of patients. Certainly if the disease has becomeRead More ›

Listening to the Biology of Prostate Cancer

Mon 1 Oct 2001

By Stephen B. Strum, M.D. Reprinted from PCRI Insights October 2001 vol. 4, no. 4 Hormonal manipulation plays an important part in the management of prostate cancer at all stages of this disease. The common denominator of these endocrine therapies is the alteration in biologic milieu characterized by androgen deprivation. At the most fundamental level,Read More ›

The Importance of Concordance in Prostate Cancer Management

Sun 1 Oct 2000

Prepared by the PCRI Helpstaff with oversight by Stephen B. Strum, MD Reprinted from PCRI Insights October 2000 vol. 3, no. 3 Concordance is a concept that is pertinent when the cell population of the tumor is not homogeneous but rather is heterogeneous. If the tumor cell population is heterogeneous, it may be more orRead More ›